Amro Stino, MD is an Associate Professor in the Department of Neurology in the University of Michigan Medical School, Division of Neuromuscular Medicine. Dr. Stino has expertise in the treatment of neuromuscular disorders, with special clinical and research interest in the care of patients with acquired peripheral neuropathy.
A native of Ann Arbor, MI and a product of Ann Arbor schools, Dr. Stino went on to pursue a Bachelor of Science degree in Brain, Behavioral, and Cognitive Sciences from the University of Michigan, Ann Arbor, which he completed in 2006. He received his medical degree from Wayne State University School of Medicine in Detroit, MI in 2010 and completed a transitional year internship at St. Joseph Mercy Hospital, in Ann Arbor, MI. He then completed his neurology residency training at the Wayne State University, School of Medicine – Detroit Medical Center, followed by a fellowship in clinical neurophysiology / neuromuscular medicine at The Mayo Clinic in Arizona. He joined The Ohio State University faculty in 2015 as Director of the Peripheral Neuropathy Clinic and Autonomic Lab, where he helped obtain CIDP and CMT center of excellence accreditation. He joined the University of Michigan faculty in 2019. He currently serves as Director of the Peripheral Neuropathy Center and Director of the Autonomic Lab, where he also secured CIDP center of excellence accreditation in 2020.
Dr. Stino is actively involved in peripheral neuropathy research and serves as site principal investigator on numerous multi-center trials in cryptogenic, diabetic, and autoimmune neuropathy. He has particular interest in GBS, CIDP, and anti-MAG neuropathy, where he investigates new drug therapies and the optimization of outcome measures.
He enjoys working alongside and mentoring neuromuscular fellows, neurology residents, and medical students who rotate with him in clinic or inpatient service. He is an active member of the Peripheral Nerve Society and the American Academy of Neuromuscular and Electrodiagnostic Medicine.
Areas of Interest
Research interests include the evaluation of drug therapies and outcome measures in patients with autoimmune, diabetic, and cryptogenic polyneuropathy.
Peripheral neuropathy; autoimmune neuropathy; autoimmune myopathy; and myasthenia.
Some patients with long-term Covid symptoms are getting more potential treatment options as doctors diagnose them with a little-known syndrome called POTS.
Medical School or Training
- Wayne State University School of Medicine, 2010
- Detroit Medical Center - Wayne State University, Neurology, MI, 2014
- Clinical Neurophysiology, Mayo Clinic, 2015
- Electrodiagnostic Medicine
- Clinical Neurophysiology